Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins
Miscarriage · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in miscarriage rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes onlyRR 1.2 [0.71, 2.04]7 studies · 970 participantsLow